Details of the Drug

General Information of Drug (ID: DMRYH3M)

Drug Name
ADP-A2M4
Indication
Disease Entry ICD 11 Status REF
Synovial sarcoma 2B5A Phase 2 [1]
Solid tumour/cancer 2A00-2F9Z Phase 1 [2]
Cross-matching ID
TTD ID
D2YT5I
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Melanoma-associated antigen 4 (MAGEA4) TT9EQUY MAGA4_HUMAN Not Available [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Clinical pipeline report, company report or official report of Adaptimmune.
2 Clinical pipeline report, company report or official report of Adaptimmune.